Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05154461
What this trial is testing

Intestinal Ketone Bodies Interfere With the Glycemic Control

Who this might be right for
Healthy Adult Volunteers
Göteborg University 8
Not applicableStudy completedNCT00923962
What this trial is testing

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 35
Not applicableStudy completedNCT02971631
What this trial is testing

Gastrectomy, Eating Behaviour and GLP-1

Who this might be right for
Gastric CancerDumping Syndrome
Cambridge University Hospitals NHS Foundation Trust 5
Early research (Phase 1)Study completedNCT01686945
What this trial is testing

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565611
What this trial is testing

Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

Who this might be right for
Obesity
Palatin Technologies, Inc 108
Not applicableStudy completedNCT04904133
What this trial is testing

Effects of Low/No Calorie Sweeteners on Glucose Tolerance

Who this might be right for
Healthy PopulationGlucose Tolerance
Acibadem University 42
Not applicableNot Yet RecruitingNCT07787936
What this trial is testing

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

Who this might be right for
Heart Failure With Preserved Ejection FractionObesityDiastolic Heart Failure+2 more
Miedziowe Centrum Zdrowia SA 150
Not applicableLooking for participantsNCT07091500
What this trial is testing

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Who this might be right for
ObesitySkeletal MuscleBrain Connectivity
Washington University School of Medicine 40
Not applicableActive Not RecruitingNCT06467604
What this trial is testing

CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users

Who this might be right for
Obesity
University of California, Davis 7
Not applicableLooking for participantsNCT07605572
What this trial is testing

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Who this might be right for
Dry Eye Disease (DED)Diabete MellitusGLP-1+3 more
Attikon Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT01257464
What this trial is testing

Sitagliptin in Cystic Fibrosis-Related Diabetes

Who this might be right for
Cystic Fibrosis
University of British Columbia 3
Testing effectiveness (Phase 2)Looking for participantsNCT07497399
What this trial is testing

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 120
Not applicableStudy completedNCT02569684
What this trial is testing

Effects of Prebiotics on GLP-1 in Type 2 Diabetes

Who this might be right for
Diabetes Type 2
Oslo University Hospital 37
Testing effectiveness (Phase 2)WithdrawnNCT02697253
What this trial is testing

Mechanisms Underlying Predictors of Success From Obesity Surgery

Who this might be right for
Obesity
Icahn School of Medicine at Mount Sinai
Not applicableStudy completedNCT00940134
What this trial is testing

Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.

Who this might be right for
Obesity
University of Copenhagen 24
Large-scale testing (Phase 3)Study completedNCT01270789
What this trial is testing

LIraglutide and Beta-cell RepAir (LIBRA) Study

Who this might be right for
Type 2 Diabetes
Mount Sinai Hospital, Canada 63
Not applicableEnrolling By InvitationNCT07404150
What this trial is testing

Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in Women With Obesity

Who this might be right for
Obesity and Cardiovascular Risk
Heather Conradson 60
Large-scale testing (Phase 3)Study completedNCT00712673
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 680
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Large-scale testing (Phase 3)Study completedNCT02635386
What this trial is testing

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromeObesity
Woman's 119
Next Page